Zenoxa 150 Tablet contains Oxcarbazepine 150 mg, an anticonvulsant medication primarily indicated for the management of partial seizures in adults and children aged 4 years and above. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing synaptic impulse propagation through blockade of voltage-sensitive sodium channels. This mechanism helps to control seizure activity and prevent seizure recurrence. Zenoxa 150 is also utilized as adjunctive therapy in the treatment of epilepsy and may be prescribed off-label for certain mood disorders such as bipolar disorder. The tablet should be administered orally, with dosage individualized based on patient response and tolerability. Common adverse effects include dizziness, somnolence, headache, nausea, and hyponatremia; therefore, periodic monitoring of serum sodium levels is recommended during therapy. Caution is advised in patients with a history of hypersensitivity to carbamazepine or oxcarbazepine, as cross-reactivity may occur. Dose adjustments may be necessary in hepatic or renal impairment. Zenoxa 150 should be used under strict medical supervision, with careful consideration of drug interactions, particularly with other antiepileptic drugs and oral contraceptives. Patient adherence to prescribed dosing and regular follow-up are essential for optimal therapeutic outcomes.